The video advertising broker crushes estimates as deals for "programmatic TV," mobile, and display ads comprise 20% of second-quarter client spending.
Shares rise nearly 5% in late trading as management announces a $1 billion buyback; cost controls lead to higher operating margin and returns on capital.
The Affordable Care Act is transforming the way we receive medical care, but is it also cutting workers' hours and killing jobs in America?
What if medical marijuana turns out not to be the wonder drug that some researchers and activists claim it could be?
Can your stomach handle the risk associated with these potentially high-flying biotech growth stocks?
The marijuana industry has fought a number of uphill battles, but gaining access to basic financial services is proving to be one of its toughest hurdles yet.
Investors focus on another top-line miss as the wireless networker makes pogress selling gear to enterprise clients.
Surprising growth leads to a beat on the top and bottom lines, while fueling big cash-flow gains. Better-than-expected Q3 revenue outlook also pushes shares higher.
Management touts more than $1 billion in theatrical backlog, and 16 new original television series in development, as revenue falls short of targets.
AMC's first globally distributed original prepares to debut as AMC reports lagging results in its international division.